SCG Cell Therapy Pte. Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by SCG Cell Therapy Pte. Ltd.
RECRUITINGPhase 1NCT06617000
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
This is a Phase I clinical study aimed to assess the safety, tolerability, and efficacy of SCG101 monotherapy for patients with HBV-HCC.
Sponsor: SCG Cell Therapy Pte. Ltd.Enrolling: 387 locations
HCCHepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma
RECRUITINGPhase 1 / Phase 2NCT05417932
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
This Phase 1/ 2a study is a multicenter study to evaluate the safety, tolerability and efficacy of SCG101 in subjects with hepatitis B virus-related hepatocellular carcinoma
Sponsor: SCG Cell Therapy Pte. Ltd.Enrolling: 466 locations
Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent